The Food and Drug Administration (FDA) has authorized second booster shots, and fourth shots overall, of the Pfizer-BioNTech and Moderna COVID-19 vaccines for Americans 50 and older, the companies announced Tuesday morning.

Immunocompromised adults over the age of 12 can also now receive an additional Pfizer dose, and those 18 and older are eligible for Moderna’s fourth shot. The second booster is to be distributed four months after the first.

Americans 12 and older with particularly weak immune systems because of a serious condition are now eligible for a fifth shot four months after the previous, the agency also decided.

The FDA approval comes as uptake for the additional shots in the U.S. wanes and both Covid cases and deaths reach the lowest points since well before the Omicron-fueled winter virus surge. 

Source: | This article originally belongs to

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Symptoms, like pain and fatigue, often cluster in newly diagnosed multiple sclerosis

Demyelination by MS. The CD68 colored tissue shows several macrophages in the…

Eye-catching experiment reduces rudeness in operating theaters

Eye-catching experiment reduces rudeness in operating theaters – A simple but powerful…

Researchers identify the sleeping habit that could make you twice as likely to get diabetes

[ad_1] The way in which all Americans sleep can be divided into…

Why you still might NOT be able to get a face-to-face GP appointment on a Saturday or evening

An NHS contract that forces GPs to work Saturdays and weekday evenings…